Latest Alzheimer’s News: More Disappointments

English: An AD Tangle Polski: Splątek neurofib...
English: An AD Tangle Polski: Splątek neurofibrylarny w chorobie Alzheimera (AD) Русский: Нейрофибриллярный клубок, образуемый тау-белком. (Photo credit: Wikipedia)

In the latest Alzheimer’s news, Eli Lilly’s, Solanezumub,  (where do they get these drug names?)shows some hope for mild cases of Alzheimer’s, but not for more advanced cases.

The drug is not due for FDA approval any time soon because its goal was to aggressively alter the destruction of Alzheimer’s for the more advanced cases.  That goal has not been reached.

As always, we’re being told each new drug being tested can make a difference, even if it is only a small improvement.  That is hopeful, but we still have the same problem of massive numbers of our elderly suffering from  brain cell destruction.

In fact, there are an estimated 35 million people suffering from Alzheimer’s today with 5 million of them living in the U.S.  Each person generally lives four to eight years after diagnosis, which means the disease may be pretty far advanced by the time it is caught.

There are no drugs today which can stop or reverse this terrible disease.

However, there is one finding which does give some hope.  Researchers have found the length of mitochondria in neutrons prevents Alzheimer’s.   This is based on the  Tau, which binds to the microtubles in cells.

If the Tau does not adhere properly, it can cause problems with  neurofibrillary tangles. Here is an eye-opening article discussing this discovery recently talked about in the publication, Neuron.


More information about  Alzheimer’s


Enhanced by Zemanta
Be Sociable, Share!


Leave a Reply

Your email address will not be published. Required fields are marked *

CommentLuv badge